Shiva Malek

7PUBLICATIONS
55CO-AUTHORS
Molecular targetsCancer geneticsMathematical aspects of classical mechanics, quantum mechanics and quantum information theory
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

|Jun 11, 2026
Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy response.

|Sep 21, 2021
RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy.

Kyung W Song, Kyle A Edgar, Emily J Hanan

|Sep 09, 2021
Biology, technology and a bit of serendipity: an interview with Shiva Malek.

Shiva Malek

|May 06, 2021
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.

Ivana Yen, Frances Shanahan, Jeeyun Lee

|Apr 03, 2021
Emerging Trends in Cancer Drug Discovery-From Drugging the "Undruggable" to Overcoming Resistance.

Joachim Rudolph, Jeff Settleman, Shiva Malek

Pageof 2

Frequent Collaborators

2 joint publications

Nicholas P D Liau

2 joint publications

Jawahar Sudhamsu

2 joint publications

Amanda R Moore

1 joint publications

Avinashnarayan Venkatanarayan